×

Compositions for treating obesity and insulin resistance disorders

  • US 8,846,724 B2
  • Filed: 07/27/2011
  • Issued: 09/30/2014
  • Est. Priority Date: 12/29/2003
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method of treating an insulin resistance disorder in a subject in need thereof, comprising administering to a subject in need thereof a therapeutically effective amount of a sirtuin-activating compound, or salt thereof, wherein the sirtuin-activating compound, or salt thereof, has at least about 2-fold less antioxidant activity than resveratrol, and wherein the sirtuin-activating compound, or salt thereof, is not a compound selected from the group consisting of a flavone, myricetin, quercetin, fisetin, kaempferol, a catechin, nordihydroguaiaretic acid (NDGA) and caffeic acid phenethyl ester.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×